ACQUIREDT+30
Clarus Capital I, Clarus Capital I- LVF 1, Clarus Capital I-LVF2
RPG Life Sciences Ltd · NSE
+37,463 sh
Filed 1 Oct 2026SEBI SASTview source
FII holding ~flat QoQ
Sept 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Sep 2025 73.0%, Dec 2025 73.0%, Mar 2026 73.0%, Jun 2026 73.0%.
FII
— +0.1pp
FII holding by quarter: Sep 2025 1.1%, Dec 2025 1.0%, Mar 2026 0.9%, Jun 2026 0.9%.
DII
— +1.2pp
Clarus Capital I, Clarus Capital I- LVF 1, Clarus Capital I-LVF2
RPG Life Sciences Ltd · NSE
+37,463 sh
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
73 announcements on record for this company.
DII holding by quarter: Sep 2025 6.7%, Dec 2025 7.0%, Mar 2026 7.5%, Jun 2026 8.7%.
MF
— 0.0pp
MF holding by quarter: Sep 2025 3.2%, Dec 2025 0.0%, Mar 2026 0.0%, Jun 2026 0.0%.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Sep 2025 73.0%, Dec 2025 73.0%, Mar 2026 73.0%, Jun 2026 73.0%.
FII
— +0.1pp
FII holding by quarter: Sep 2025 1.1%, Dec 2025 1.0%, Mar 2026 0.9%, Jun 2026 0.9%.
DII
— +1.2pp
DII holding by quarter: Sep 2025 6.7%, Dec 2025 7.0%, Mar 2026 7.5%, Jun 2026 8.7%.
MF
— 0.0pp
MF holding by quarter: Sep 2025 3.2%, Dec 2025 0.0%, Mar 2026 0.0%, Jun 2026 0.0%.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
73 announcements on record for this company.